SCHEMBL20064079

SCHEMBL20064079

NC1CCC(CCc2ncccn2)C1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CPB1 P15086 1/20 0.32
CPB2 Q96IY4 1/20 0.32
MAPK8 P45983 1/20 0.30
MERTK Q12866 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011306 0.73 MAP4K4 (0.36) MAPK8MERTK
SCHEMBL5549154 0.70 GRIN2B (0.42) MERTK
SCHEMBL5549157 0.70 GRIN2B (0.42) MERTK
SCHEMBL5543259 0.70 GRIN2B (0.42) MERTK
SCHEMBL5543254 0.70 GRIN2B (0.42) MERTK
SCHEMBL5545337 0.70 CRBN (0.41) CPB1CPB2
SCHEMBL5545416 0.69 CRBN (0.46)
SCHEMBL17592449 0.69 HRH1 (0.42)
SCHEMBL27394629 0.66 IDO1 (0.43)
SCHEMBL1220398 0.65 MAP4K4 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069863-A1 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-19 WO disclosed